Zhong-Zhen Guan

677 total citations
13 papers, 488 citations indexed

About

Zhong-Zhen Guan is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhong-Zhen Guan has authored 13 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhong-Zhen Guan's work include Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (4 papers) and Viral-associated cancers and disorders (3 papers). Zhong-Zhen Guan is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (4 papers) and Viral-associated cancers and disorders (3 papers). Zhong-Zhen Guan collaborates with scholars based in China, Switzerland and United Kingdom. Zhong-Zhen Guan's co-authors include Bruce J. Giantonio, Josep Tabernero, Lada Mitchell, Herbert I. Hurwitz, Daniel Waterkamp, Fairooz F. Kabbinavar, Niall C. Tebbutt, Rui‐Hua Xu, Wen-Qi Jiang and Yang Zhang and has published in prestigious journals such as The Oncologist, BMC Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Zhong-Zhen Guan

13 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhong-Zhen Guan China	10	365	157	111	105	77	13	488
D. Turci Italy	14	492 1.3×	250 1.6×	120 1.1×	81 0.8×	109 1.4×	43	637
Nicolas Moosmann Germany	12	449 1.2×	216 1.4×	107 1.0×	89 0.8×	84 1.1×	39	512
L. Cals France	15	495 1.4×	253 1.6×	80 0.7×	65 0.6×	109 1.4×	41	674
Swee‐Peng Yap Singapore	7	287 0.8×	255 1.6×	45 0.4×	98 0.9×	59 0.8×	9	532
Aimery de Gramont France	9	428 1.2×	120 0.8×	143 1.3×	67 0.6×	95 1.2×	12	548
Yong Mun United States	11	313 0.9×	115 0.7×	50 0.5×	79 0.8×	57 0.7×	43	464
D. Khayat France	10	166 0.5×	56 0.4×	68 0.6×	80 0.8×	51 0.7×	28	430
Yangkui Gu China	11	130 0.4×	154 1.0×	169 1.5×	53 0.5×	137 1.8×	25	425
P. Comella Italy	19	656 1.8×	378 2.4×	82 0.7×	68 0.6×	143 1.9×	65	829
C. Farley United States	10	397 1.1×	282 1.8×	39 0.4×	76 0.7×	69 0.9×	20	605

Countries citing papers authored by Zhong-Zhen Guan

Since Specialization

Citations

This map shows the geographic impact of Zhong-Zhen Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong-Zhen Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong-Zhen Guan more than expected).

Fields of papers citing papers by Zhong-Zhen Guan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong-Zhen Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong-Zhen Guan. The network helps show where Zhong-Zhen Guan may publish in the future.

Co-authorship network of co-authors of Zhong-Zhen Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong-Zhen Guan. A scholar is included among the top collaborators of Zhong-Zhen Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong-Zhen Guan. Zhong-Zhen Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Yu, Wen-Qi Jiang, Hui-Lan Rao, et al.. (2015). Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP. Annals of Hematology. 94(11). 1865–1873. 16 indexed citations

Hurwitz, Herbert I., Niall C. Tebbutt, Fairooz F. Kabbinavar, et al.. (2013). Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials. The Oncologist. 18(9). 1004–1012. 176 indexed citations

Su, Li, He Huang, Hai Liao, et al.. (2012). Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results. International Journal of Clinical Pharmacology and Therapeutics. 51(2). 96–105. 6 indexed citations

Guan, Zhong-Zhen, Jian-Ming Xu, Lin Shen, et al.. (2011). Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial. Chinese Journal of Cancer. 30(10). 682–689. 96 indexed citations

Xia, Yi, Wen-Qi Jiang, Jia-Jia Huang, et al.. (2011). Clinical characteristics and prognostic factors in Chinese patients with Hodgkin’s lymphoma. Medical Oncology. 29(2). 1127–1133. 9 indexed citations

Huang, Jia-Jia, Wen-Qi Jiang, Rui‐Hua Xu, et al.. (2010). Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors. BMC Cancer. 10(1). 358–358. 28 indexed citations

Xia, Liang-Ping, Peihong Wu, Jian‐Chuan Xia, et al.. (2010). One patient with metastastic colorectal cancer successfully treated by combination of targeted agents after failure of chemotherapy. Chinese Journal of Cancer. 29(12). 1023–1028. 2 indexed citations

Guan, Zhong-Zhen, Feng-yi Feng, Zefei Jiang, et al.. (2009). Superior efficacy of a Cremophor‐free albumin‐bound paclitaxel compared with solvent‐based paclitaxel in Chinese patients with metastatic breast cancer. Asia-Pacific Journal of Clinical Oncology. 5(3). 165–174. 22 indexed citations

Luo, Hui, Rui‐Hua Xu, Li Zhang, et al.. (2008). A Pilot Study of Oxaliplatin, Fluorouracil and Folinic Acid (FOLFOX-6) as First-Line Chemotherapy in Advanced or Recurrent Gastric Cancer. Chemotherapy. 54(3). 228–235. 17 indexed citations

10.

Li, Yu-Hong, Feng-Hua Wang, Wen-Qi Jiang, et al.. (2008). The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma. Annals of Hematology. 87(6). 481–485. 34 indexed citations

11.

Xia, Zhong-Jun, et al.. (2008). Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma. International Journal of Clinical Oncology. 13(5). 436–441. 8 indexed citations

12.

Zhang, Li, et al.. (2007). Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy. Cancer Chemotherapy and Pharmacology. 61(1). 33–38. 58 indexed citations

13.

Zhang, Xing, Bo Wang, Xiao-Shi Zhang, et al.. (2007). Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning. BMC Cancer. 7(1). 235–235. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact